Treatment of Left Axis Deviation
Left axis deviation itself is not treated—treatment is directed at the underlying cardiac condition causing the LAD. 1
Initial Diagnostic Approach
The first step is determining whether LAD represents a benign finding or indicates significant underlying pathology:
- Evaluate for specific arrhythmias requiring immediate treatment, particularly if the patient presents with symptoms of tachycardia 2, 1
- Assess for structural heart disease through echocardiography in patients with symptoms suggestive of cardiovascular disease or family history of cardiomyopathy or sudden cardiac death 1
- Look for additional ECG abnormalities including non-voltage criteria for left ventricular hypertrophy, conduction abnormalities, and repolarization changes 1
Treatment Based on Specific Underlying Conditions
Left Ventricular Fascicular Tachycardia (RBBB morphology with LAD)
For patients presenting with left ventricular fascicular tachycardia, intravenous verapamil or beta-blockers should be given as first-line therapy. 2
- First-line pharmacologic options: Beta-blockers, verapamil, or sodium channel blockers (class IC agents) 1
- First-line interventional approach: Catheter ablation in experienced centers is recommended as primary treatment 1
- Second-line option: Catheter ablation by experienced operators after failure of medical therapy or in patients not wanting long-term drug therapy 1
Tricuspid Annular Tachycardia with LAD
- First-line treatment: Beta-blockers, verapamil, or sodium channel blockers (class IC agents) 1
- Second-line treatment: Catheter ablation by experienced operators after failure of medical therapy 1
Bundle Branch Re-entrant Tachycardia (LBBB morphology with LAD)
Catheter ablation of one of the bundle branches (preferably the right bundle branch) is curative and recommended as definitive treatment. 2
- The right bundle branch is the preferred ablation target as it is more easily accessible 2
- Concomitant ICD placement should be strongly considered since the underlying structural abnormality remains unchanged after ablation 2
Dilated Cardiomyopathy with LAD
Optimal medical therapy with ACE inhibitors, beta-blockers, and mineralocorticoid receptor antagonists is recommended to reduce the risk of sudden death and progressive heart failure. 2
- ICD implantation is recommended in patients with DCM and hemodynamically not tolerated VT/VF who are expected to survive >1 year with good functional status 2
- ICD is also recommended in patients with symptomatic heart failure (NYHA class II-III) and ejection fraction ≤35% despite ≥3 months of optimal pharmacological therapy 2
- Amiodarone should be considered in patients with ICD experiencing recurrent appropriate shocks despite optimal device programming 2
- Catheter ablation is recommended for bundle branch re-entry ventricular tachycardia refractory to medical therapy 2
Important Contraindications
- Sodium channel blockers and dronedarone are not recommended for treating ventricular arrhythmias in patients with dilated cardiomyopathy 2
- Amiodarone is not recommended for treatment of asymptomatic non-sustained VT in patients with DCM 2
Common Pitfalls to Avoid
- Do not treat LAD as a primary diagnosis—it is an ECG finding that requires identification of the underlying cause 3
- Do not overlook age-related changes—mild LAD becomes more common with increasing age and may represent a longstanding, benign finding 3
- Promptly identify and treat arrhythmogenic factors including pro-arrhythmic drugs, hypokalemia, and thyroid disease in patients with DCM and ventricular arrhythmias 2
- Consider that LAD in the setting of left bundle branch block indicates more advanced myocardial disease with greater scar burden and worse prognosis 4, 5